ESR1 Mutation Detection and Dynamics in Meningeal Carcinomatosis in Breast Cancer

ESR1 mutation is frequently encountered in hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC), especially after aromatase inhibitor (AI) therapy, as a mechanism of resistance to endocrine therapy. Circulating tumor DNA-based detect...

Descripción completa

Detalles Bibliográficos
Autores principales: Carausu, Marcela, Melaabi, Samia, Pierga, Jean-Yves, Bidard, François-Clément, Cabel, Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192750/
https://www.ncbi.nlm.nih.gov/pubmed/32395380
http://dx.doi.org/10.4048/jbc.2020.23.e4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192750/
https://www.ncbi.nlm.nih.gov/pubmed/32395380
http://dx.doi.org/10.4048/jbc.2020.23.e4

Ejemplares similares